Navigation Links
Cancer that colonizes our bodies

To Robert C. von Borstel, cancer is a metaphorical example of the perfect invasion by a founder species. Like the first pregnant finch that landed on a deserted island in the Galapagos Archipelago, the first cancer cell in the human body has to undergo many mutations through many generations to establish itself as an invader of different organs in the body. But once it is there, like any newly stabilized species in different ecological niches, cancer is tough to get rid of.

The former University of Alberta biologist has been working with DNA ?the molecule that carries our cells?genetic information ?ever since 1947, six years before its structure was described by Watson and Crick. His fundamental Natural Sciences and Engineering Research Council (NSERC) work on how radiation can kill cells, how the DNA molecule itself can control mutation, and other research has earned him a fellowship in the American Association for the Advancement for Science (AAAS).

Now, von Borstel, at the AAAS conference in San Francisco, to be held between Feb. 15 and 19, will deliver a talk about how cancer cell mutation and selection are metaphorically similar to how a new species begins its evolution.

"Of course, the difference with cancer is that it destroys itself when it kills you off, whereas many new species stabilize," von Borstel says. "Obviously, no metaphor is the be-all of reality. But I’m hoping this symposium I am hosting will help people look at cancer in a new light."

After growing up on a wheat and cattle ranch in Oregon, von Borstel was drafted into the U.S. Navy as a seaman first-class in 1944. Following the Second World War, he pursued his university education in the United States and joined Tennessee’s Oak Ridge National Laboratory in 1953, where he studied the effects of radiation on insects, and described the mechanisms by which control of insect pests by X-irradiation is achieved.

From there, he accepted a position as chai
'"/>

Source:Natural Sciences and Engineering Research Council


Page: 1 2

Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. Jump-starting T Cells In Skin Cancer
3. Deficient DNA Repair Capacity Associated With Increased Risk Of Breast Cancer
4. Fox Chase Cancer Center scientists identify immune-system mutation
5. Breakthrough Microarray-based Technology for the Study of Cancer
6. Yale Scientists Find MicroRNA Regulates Ras Cancer Gene
7. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
8. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
9. Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer
10. New Breast Cancer Test Could Save Lives
11. Estrogen-like Component of Plastic Stimulates Growth of Certain Prostate Cancer Cells

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cancer that colonizes our bodies

(Date:11/23/2009)...wine vaccine available for the H1N1 virus has been...virus. The vaccination marks the first time vaccin... pandemic flu., Iowa State University,s Hank Har...ccine this summer and has been shipping preventive...nois for several weeks., The latest vaccines wer...
(Date:11/23/2009)...studies reveal in unprecedented detail how the rib...ew proteins and guide them toward their destinatio...dynamics flexible fitting (MDFF) to examine the in...ular partners. , The first study, in Proceedin...the intimate signaling between the ribosome and an...
(Date:11/23/2009)... General Medical Sciences (NIGMS), part of the Nat....3 million for grants in scientific areas it ident... the GO grant program to stimulate biomedical rese...merican Recovery and Reinvestment Act (Recovery Ac...to have a significant impact on a field of biomedi...
Breaking Biology News(10 mins):Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3HeartWare to Present at Upcoming Investment Conferences in November 60817 1HeartWare to Present at Upcoming Investment Conferences in November 60817 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnersh 14747 1Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnersh 14747 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnersh 14747 3SleepApneaUSA net Announced An Immediate Alternative Sleep Apnea Solution In Response To The NTSB 26apos 3Bs Sleep Apnea Testing Recommendations 60813 1SleepApneaUSA net Announced An Immediate Alternative Sleep Apnea Solution In Response To The NTSB 26apos 3Bs Sleep Apnea Testing Recommendations 60813 2SleepApneaUSA net Announced An Immediate Alternative Sleep Apnea Solution In Response To The NTSB 26apos 3Bs Sleep Apnea Testing Recommendations 60813 3SleepApneaUSA net Announced An Immediate Alternative Sleep Apnea Solution In Response To The NTSB 26apos 3Bs Sleep Apnea Testing Recommendations 60813 4SleepApneaUSA net Announced An Immediate Alternative Sleep Apnea Solution In Response To The NTSB 26apos 3Bs Sleep Apnea Testing Recommendations 60813 5
... expanding into new territory, successfully aiding...valves in patients too sick to withstand open-ches...th Annual Scientific Sessions of the Society for C..., May 9?2, 2007, in Orlando, FL, patients who were...Valve, Irvine, CA) experienced improvements in bot...
...e use of tissue-engineered scaffolding made of car... naturally, to replace defective cartilage tissue....caffold which is implanted into the body, where ne...he study appears in the journal Artificial Organs....d mice as the study found these scaffolds to be a ...
...e-dose anticlotting medication just before percuta...d risk of heart attack and cardiac death by half, ...cientific Sessions of the Society for Cardiovascul...2007, in Orlando, FL. , Researchers found that gi...e stenting, rather than the standard 300-mg dose, ...
Other Biology News:Percutaneous aortic valve replacement safe, successful in high-risk patients 2High-dose anticlotting drug cuts heart attack, death risk in half 2
(Date:11/20/2009)... METTLER TOLEDO recently announced that a...ptimization Using At-Line Particle Characterizatio...In this webinar, the application of in situ partic...ign space and optimize a series of roller compacti...nd roller compaction forces. , ...
(Date:11/19/2009)...AGEN, Nov. 19 Danish Prince Joachi...ic ethanol plant in Kalundborg, Denmark, on Wednes...,s first and largest 2nd generation ethanol demons...mes are used in the plant,s innovative process for... Danisco, was the first to market with commercial ...
(Date:11/19/2009)... ,, BETHESDA, Md., Nov. 19 /PRNewswire-FirstCal...novator in biotechnology for diabetes therapy, and... services to food, supplement, biotechnology and p... the previously reported $6.3 million registered d...0,870 shares of its common stock and warrants to p...
(Date:11/19/2009)...ALVERN, Pa. and WALTHAM, Mass., Nov. 19 /PRNewswir...on Resources find that the leading driver of antib...is broad-spectrum activity against gram-positive a...organisms that can cause nosocomial pneumonia, sur...imarily for agents that provide appropriate covera...
Breaking Biology Technology:Roller Compaction Process Optimization Using At-Line Particle Characterization 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3
... 16 ,Boston Scientific Corporation (NYSE: BSX ) a...the signing of a definitive merger agreement, unde... price of $1.35 per share of,CryoCor, or approxima...elopment agreement, in place since June 2007, to p...n, or "Afib." Afib is the most common,cardiac arrh...
... Inc.,announced today that it has closed the secon...cing. As previously announced, Aisling Capital led...ew investors, the D.E. Shaw,group and Boston Life ...omura Phase4 Ventures, Novartis BioVentures, BioFu... Hentsch, BioVeda Fund and Hercules,Technology Gro...
... Oncolytics Biotech Inc.,("Oncolytics") (TSX:ONC, ...er and his research group at St. James,s Universit...their work in the April 10 online issue of,Gene Th...Cell Killing by,Oncolytic Reovirus for the Treatme...eovirus effectively kills and replicates,in both h...
Other Biology Technology:Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement 2Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement 3Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement 4Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement 5Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement 6Paratek Pharmaceuticals Completes $40 Million Private Placement to Finance Clinical Programs Including Oral Antibiotic to Combat MRSA and Other Infections 2Paratek Pharmaceuticals Completes $40 Million Private Placement to Finance Clinical Programs Including Oral Antibiotic to Combat MRSA and Other Infections 3Oncolytics Biotech Inc. Announces Gene Therapy Publication on Reovirus Treatment for Melanoma 2
...RS are multi-functional mixing devices. Stepping m... solid, heavy-duty durable shaker to provide a uni...ature. Regulated action scale for all modes. Micro...trol time, continuous time, action scale and speed...
Finnigan LTQ FT from Thermo Scientific
PDQuest 10-User Network License from Bio-Rad
Mouse Anti-Human JRKL Monoclonal Antibody, Unconjugated, Clone 4E10 from Abnova Corporation
Biology Products: